Literature DB >> 18452566

Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT).

Gunilla Malm1, Britt Gustafsson, Gunilla Berglund, Maria Lindström, Karin Naess, Birgit Borgström, Ulrika von Döbeln, Olle Ringdén.   

Abstract

AIM: To follow-up six children with severe mucopolysaccharidosis type IH, Hurler syndrome, who were treated before 24 months of age with haematopoietic stem cell transplantation.
METHODS: In Sweden, during the last 10-year period, six consecutive children born with severe mucopolysaccharidoses type IH have been successfully transplanted using matched unrelated donors between the ages of 11 and 24 months (mean age 18 months). Three children received intravenous enzyme replacement therapy once a week, from diagnosis until engraftment of their bone marrow. RESULT: Two children developed chimerism and a progressive increase in recipient cells and later received a successful re-transplantation. One to two years after transplantation the children demonstrated some developmental delays in cognitive function. Latterly this was followed by normalization. Orthopaedic operations on the spine and hips and carpal tunnel syndrome were still required following transplantation. Cardiac valve involvement remained progressive in the children.
CONCLUSION: The outcome of six children in this study confirms that early haematopoietic stem cell transplantation in mucopolysaccharidosis type I, Hurler syndrome, preserves an affected child's mental ability. Consequently, it is essential that clinical recognition and early diagnosis take place, providing an additional challenge to paediatricians treating this condition.

Entities:  

Mesh:

Year:  2008        PMID: 18452566     DOI: 10.1111/j.1651-2227.2008.00811.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  20 in total

1.  Therapeutic approaches for lysosomal storage diseases.

Authors:  Gregory M Pastores
Journal:  Ther Adv Endocrinol Metab       Date:  2010-08       Impact factor: 3.565

2.  Delivering drugs to the central nervous system: an overview.

Authors:  Patricia I Dickson
Journal:  Drug Deliv Transl Res       Date:  2012-06       Impact factor: 4.617

3.  The craniocervical junction following successful haematopoietic stem cell transplantation for mucopolysaccharidosis type I H (Hurler syndrome).

Authors:  Elke Miebach; Heather Church; Alan Cooper; Jean Mercer; Karen Tylee; Robert F Wynn; J Edmond Wraith
Journal:  J Inherit Metab Dis       Date:  2011-03-17       Impact factor: 4.982

4.  Neurocognition across the spectrum of mucopolysaccharidosis type I: Age, severity, and treatment.

Authors:  Elsa G Shapiro; Igor Nestrasil; Kyle Rudser; Kathleen Delaney; Victor Kovac; Alia Ahmed; Brianna Yund; Paul J Orchard; Julie Eisengart; Gregory R Niklason; Julian Raiman; Eva Mamak; Morton J Cowan; Mara Bailey-Olson; Paul Harmatz; Suma P Shankar; Stephanie Cagle; Nadia Ali; Robert D Steiner; Jeffrey Wozniak; Kelvin O Lim; Chester B Whitley
Journal:  Mol Genet Metab       Date:  2015-06-17       Impact factor: 4.797

Review 5.  Therapeutic liver repopulation for phenylketonuria.

Authors:  Cary O Harding; K M Gibson
Journal:  J Inherit Metab Dis       Date:  2010-05-22       Impact factor: 4.982

6.  Long-term functional outcomes of children with hurler syndrome treated with unrelated umbilical cord blood transplantation.

Authors:  Hannah Y Coletti; Mieke Aldenhoven; Karina Yelin; Michele D Poe; Joanne Kurtzberg; Maria L Escolar
Journal:  JIMD Rep       Date:  2015-01-23

7.  Biomarkers of bone remodeling in children with mucopolysaccharidosis types I, II, and VI.

Authors:  David A Stevenson; Kyle Rudser; Alicia Kunin-Batson; Ellen B Fung; David Viskochil; Elsa Shapiro; Paul J Orchard; Chester B Whitley; Lynda E Polgreen
Journal:  J Pediatr Rehabil Med       Date:  2014

8.  Fatal and unanticipated cardiorespiratory disease in a two-year-old child with hurler syndrome following successful stem cell transplant.

Authors:  Sampada Gupta; Anne O'Meara; Robert Wynn; Michael McDermott
Journal:  JIMD Rep       Date:  2013-03-09

Review 9.  Pathogenesis and treatment of spine disease in the mucopolysaccharidoses.

Authors:  Sun H Peck; Margret L Casal; Neil R Malhotra; Can Ficicioglu; Lachlan J Smith
Journal:  Mol Genet Metab       Date:  2016-06-04       Impact factor: 4.797

10.  Long-Term Cognitive and Functional Outcomes in Children with Mucopolysaccharidosis (MPS)-IH (Hurler Syndrome) Treated with Hematopoietic Cell Transplantation.

Authors:  A S Kunin-Batson; E G Shapiro; K D Rudser; C A Lavery; K J Bjoraker; S A Jones; R F Wynn; A Vellodi; J Tolar; P J Orchard; J E Wraith
Journal:  JIMD Rep       Date:  2016-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.